Magdalena Prokopowicz

Prof. Magdalena Prokopowicz

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Microporous and Mesoporous Materials
Verified
Journal Article
Closed access
ASAdrian Szewczyk
Adrian Szewczyk
Magdalena ProkopowiczMagdalena Prokopowicz
Magdalena Prokopowicz
WSWiesław Sawicki
Wiesław Sawicki
DMDorota Majda
Dorota Majda
GWGavin Walker
Gavin Walker

1 March 2016 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Magdalena ProkopowiczMagdalena Prokopowicz
Magdalena Prokopowicz
KCKatarzyna Czarnobaj
Katarzyna Czarnobaj
ASAdrian Szewczyk
Adrian Szewczyk
WSWiesław Sawicki
Wiesław Sawicki


9 December 2019 in Drug Delivery and Translational Research
Verified
Journal Article
Open access
PDF file
Magdalena ProkopowiczMagdalena Prokopowicz
Magdalena Prokopowicz
ASAdrian Szewczyk
Adrian Szewczyk
ASAdrianna Skwira
Adrianna Skwira
SRSadej Rafal
Sadej Rafal
GWGavin Walker
Gavin Walker
We reported the new biphasic composites of calcium phosphate and mesoporous silica material (CaP@MSi) in the form of powders and pellets as a potential bone drug delivery system for doxycycline hydrochloride (DOX). The CaP@MSi powders were synthesized by cationic surfactant-templating method. The effects of 10, 20, and 30% CaP content in the CaP@MSi powders on the molecular surface structure, the cytotoxicity against osteoblast cells in vitro, and the mineralization potential in simulated body fluid were investigated. The CaP@MSi characterized by the highest mineralization potential (30% CaP content) were used for DOX adsorption and pelletization process. The CaP which precipitated in the CaP@MSi composites was characterized as calcium-deficient with the Ca:P molar ratio between 1.0 and 1.2. The cytotoxicity assays demonstrated that the CaP content in MSi increases osteoblasts viability indicating the CaP@MSi (30% CaP content) as the most biocompatible. The combination of CaP and MSi was an effective strategy to improve the mineralization potential of parent material. Upon immersion in simulated body fluid, the CaP of composite converted into the bone-like apatite. The obtained pellets preserved the mineralization potential of CaP@MSi and provided the prolonged 5-day DOX release. The obtained biphasic CaP@MSi composites seem to have an application potential as bone-specific drug delivery system.

1 May 2012 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Magdalena ProkopowiczMagdalena Prokopowicz
Magdalena Prokopowicz
JŻJacek Żegliński
Jacek Żegliński
AGAbbasi Gandhi
Abbasi Gandhi
WSWiesław Sawicki
Wiesław Sawicki
STSyed A.M. Tofail
Syed A.M. Tofail

1 January 2007 in Journal of Microencapsulation
Verified
Journal Article
Closed access
Magdalena ProkopowiczMagdalena Prokopowicz
Magdalena Prokopowicz
APAndrzej Przyjazny
Andrzej Przyjazny
Samples of mesoporous base-catalysed silica xerogel materials made by the sol-gel process were impregnated with an anticancer drug—doxorubicin, followed by different times of ageing at room temperature. The effect of ageing time on the physical and structural properties as well as sorption–desorption of the drug was investigated. The obtained results suggest an inverse relationship with a solid density and surface area increasing as the pore size and volume decrease during ageing time. These results also revealed the effect of ageing time on the efficiency of sorption–desorption of the drug. An increase in ageing time results in an increase of the efficiency of drug sorption and a decrease in the rate of drug release.